Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.

Majzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, Rietberg SP, Linde MH, Xu P, Rota C, Sotillo E, Labanieh L, Lee DW, Orentas RJ, Dimitrov DS, Zhu Z, Croix BS, Delaidelli A, Sekunova A, Bonvini E, Mitra SS, Quezado MM, Majeti R, Monje M, Sorensen PHB, Maris JM, Mackall CL.

Clin Cancer Res. 2019 Apr 15;25(8):2560-2574. doi: 10.1158/1078-0432.CCR-18-0432. Epub 2019 Jan 17.

PMID:
30655315
2.

Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.

Hutter G, Theruvath J, Graef CM, Zhang M, Schoen MK, Manz EM, Bennett ML, Olson A, Azad TD, Sinha R, Chan C, Assad Kahn S, Gholamin S, Wilson C, Grant G, He J, Weissman IL, Mitra SS, Cheshier SH.

Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):997-1006. doi: 10.1073/pnas.1721434116. Epub 2019 Jan 2.

3.

Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.

Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, Li G, Wechsler-Reya RJ, Reimand J, Cho YJ, Taylor MD, Weissman IL, Mitra SS, Cheshier SH.

Nat Commun. 2018 Nov 2;9(1):4651. doi: 10.1038/s41467-018-07182-1.

4.

Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.

Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, Li G, Wechsler-Reya RJ, Reimand J, Cho YJ, Taylor MD, Weissman IL, Mitra SS, Cheshier SH.

Nat Commun. 2018 Oct 8;9(1):4121. doi: 10.1038/s41467-018-06564-9. Erratum in: Nat Commun. 2018 Nov 2;9(1):4651.

5.

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.

Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, Storm TA, Schubert S, Hutter G, Narayanan C, Chu P, Raabe EH, Harsh G 4th, Taylor MD, Monje M, Cho YJ, Majeti R, Volkmer JP, Fisher PG, Grant G, Steinberg GK, Vogel H, Edwards M, Weissman IL, Cheshier SH.

Sci Transl Med. 2017 Mar 15;9(381). pii: eaaf2968. doi: 10.1126/scitranslmed.aaf2968.

PMID:
28298418
6.

Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.

Leiss L, Mutlu E, Øyan A, Yan T, Tsinkalovsky O, Sleire L, Petersen K, Rahman MA, Johannessen M, Mitra SS, Jacobsen HK, Talasila KM, Miletic H, Jonassen I, Li X, Brons NH, Kalland KH, Wang J, Enger PØ.

BMC Cancer. 2017 Feb 7;17(1):108. doi: 10.1186/s12885-017-3109-8.

7.

Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.

Zhu H, Leiss L, Yang N, Rygh CB, Mitra SS, Cheshier SH, Weissman IL, Huang B, Miletic H, Bjerkvig R, Enger PØ, Li X, Wang J.

Oncotarget. 2017 Feb 14;8(7):12145-12157. doi: 10.18632/oncotarget.14553.

8.

The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway.

Assad Kahn S, Costa SL, Gholamin S, Nitta RT, Dubois LG, Fève M, Zeniou M, Coelho PL, El-Habr E, Cadusseau J, Varlet P, Mitra SS, Devaux B, Kilhoffer MC, Cheshier SH, Moura-Neto V, Haiech J, Junier MP, Chneiweiss H.

EMBO Mol Med. 2016 May 2;8(5):511-26. doi: 10.15252/emmm.201505421. Print 2016 May.

9.

Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.

Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp P, Schoen MK, McCracken MN, Majeti R, Weissman I, Mitra SS, Cheshier SH.

PLoS One. 2016 Apr 19;11(4):e0153550. doi: 10.1371/journal.pone.0153550. eCollection 2016.

10.

Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells.

Mitra SS, Feroze AH, Gholamin S, Richard C, Esparza R, Zhang M, Azad TD, Alrfaei B, Kahn SA, Hutter G, Guzman R, Creasey GH, Plant GW, Weissman IL, Edwards MS, Cheshier S.

Neurosurgery. 2015 Nov;77(5):794-802; discussion 802. doi: 10.1227/NEU.0000000000000918.

PMID:
26225855
11.

Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, Gibson EM, Mount CW, Polepalli J, Mitra SS, Woo PJ, Malenka RC, Vogel H, Bredel M, Mallick P, Monje M.

Cell. 2015 May 7;161(4):803-16. doi: 10.1016/j.cell.2015.04.012. Epub 2015 Apr 23.

12.

Glioblastoma stem cells and stem cell-targeting immunotherapies.

Esparza R, Azad TD, Feroze AH, Mitra SS, Cheshier SH.

J Neurooncol. 2015 Jul;123(3):449-57. doi: 10.1007/s11060-015-1729-x. Epub 2015 Feb 15. Review.

PMID:
25682090
13.

Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.

Feng M, Chen JY, Weissman-Tsukamoto R, Volkmer JP, Ho PY, McKenna KM, Cheshier S, Zhang M, Guo N, Gip P, Mitra SS, Weissman IL.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2145-50. doi: 10.1073/pnas.1424907112. Epub 2015 Feb 2.

14.

Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.

Nitta RT, Gholamin S, Feroze AH, Agarwal M, Cheshier SH, Mitra SS, Li G.

Oncogene. 2015 Jul;34(28):3688-99. doi: 10.1038/onc.2014.299. Epub 2014 Sep 22.

15.

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.

Emlet DR, Gupta P, Holgado-Madruga M, Del Vecchio CA, Mitra SS, Han SY, Li G, Jensen KC, Vogel H, Xu LW, Skirboll SS, Wong AJ.

Cancer Res. 2014 Feb 15;74(4):1238-49. doi: 10.1158/0008-5472.CAN-13-1407. Epub 2013 Dec 23.

16.

Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway.

Lee KS, Wu Z, Song Y, Mitra SS, Feroze AH, Cheshier SH, Lu B.

Genes Dev. 2013 Dec 15;27(24):2642-7. doi: 10.1101/gad.225169.113.

17.

BET bromodomain inhibition of MYC-amplified medulloblastoma.

Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ.

Clin Cancer Res. 2014 Feb 15;20(4):912-25. doi: 10.1158/1078-0432.CCR-13-2281. Epub 2013 Dec 2.

18.

Usp16 contributes to somatic stem-cell defects in Down's syndrome.

Adorno M, Sikandar S, Mitra SS, Kuo A, Nicolis Di Robilant B, Haro-Acosta V, Ouadah Y, Quarta M, Rodriguez J, Qian D, Reddy VM, Cheshier S, Garner CC, Clarke MF.

Nature. 2013 Sep 19;501(7467):380-4. doi: 10.1038/nature12530. Epub 2013 Sep 11.

19.

Coregulation of multiple signaling mechanisms in pp60v-Src-induced closure of Cx43 gap junction channels.

Mitra SS, Xu J, Nicholson BJ.

J Membr Biol. 2012 Aug;245(8):495-506. Epub 2012 Sep 11.

20.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.

21.

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.

Li G, Mitra SS, Monje M, Henrich KN, Bangs CD, Nitta RT, Wong AJ.

J Neurooncol. 2012 Jul;108(3):395-402. doi: 10.1007/s11060-012-0842-3. Epub 2012 Mar 2.

22.

Heterogeneous reallocation of presynaptic efficacy in recurrent excitatory circuits adapting to inactivity.

Mitra A, Mitra SS, Tsien RW.

Nat Neurosci. 2011 Dec 18;15(2):250-7. doi: 10.1038/nn.3004.

23.

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma.

Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, Attema JL, Li G, Haddix T, Edwards MS, Fisher PG, Weissman IL, Rowitch DH, Vogel H, Wong AJ, Beachy PA.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4453-8. doi: 10.1073/pnas.1101657108. Epub 2011 Mar 1.

24.

Highly variable acquisition rates of Ixodes scapularis (Acari: Ixodidae) by birds on an Atlantic barrier island.

Mitra SS, Buckley PA, Buckley FG, Ginsberg HS.

J Med Entomol. 2010 Nov;47(6):1019-27.

PMID:
21175049
25.

Development of an EGFRvIII specific recombinant antibody.

Gupta P, Han SY, Holgado-Madruga M, Mitra SS, Li G, Nitta RT, Wong AJ.

BMC Biotechnol. 2010 Oct 7;10:72. doi: 10.1186/1472-6750-10-72.

26.

The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis.

Nitta RT, Del Vecchio CA, Chu AH, Mitra SS, Godwin AK, Wong AJ.

Oncogene. 2011 Jan 13;30(2):234-44. doi: 10.1038/onc.2010.414. Epub 2010 Sep 27.

27.

Erlotinib induced skin rash spares skin in previous radiotherapy field.

Mitra SS, Simcock R.

J Clin Oncol. 2006 Jun 1;24(16):e28-9. No abstract available.

PMID:
16735697
28.

Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions.

Mallick S, Sahoo A, Mitra SS.

Boll Chim Farm. 2003 May;142(4):180-6.

PMID:
12918228
29.

Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.

Patterson H, Norman AR, Mitra SS, Nicholls J, Fisher C, Dearnaley DP, Horwich A, Mason MD, Huddart RA.

Radiother Oncol. 2001 Apr;59(1):5-11.

PMID:
11295200
30.

Temperature variations of the elastic constants of CaF2 and SrF2 crystals.

Singh RK, Mitra SS, Rao CN.

Phys Rev B Condens Matter. 1991 Jul 1;44(2):838-840. No abstract available.

PMID:
9999192
31.

Finite difference solution for graded-index cylindrical dielectric waveguides: a scalar wave approximation.

Tamil LS, Mitra SS, Dutta R, Pereira JM.

Appl Opt. 1991 Mar 20;30(9):1113-6. doi: 10.1364/AO.30.001113.

PMID:
20582113
32.

Optical absorption characteristics of neutron irradiated heavy metal fluoride glasses.

Mitra SS, Banerjee PK, Pereira JM, Gedam SG.

Appl Opt. 1987 Oct 15;26(20):4443-6. doi: 10.1364/AO.26.004443.

PMID:
20523382
33.

Effect of P. vivax malaria on G-6-PD pH-optima of host red cells.

Bhattachariya J, Mitra SS.

J Commun Dis. 1986 Sep;18(3):208-14. No abstract available.

PMID:
3553313
34.

The clinical and hematological profile of thalassemia and hemoglobinopathies in India.

Mitra SS.

Indian Pediatr. 1983 Oct;20(10):701-13. No abstract available.

PMID:
6676274
35.

Three-photon absorption in direct-gap crystals.

Mitra SS, Judell NH, Vaidyanathan A, Guenther AH.

Opt Lett. 1982 Jul 1;7(7):307-9.

PMID:
19714002
36.

Diagnosis of leukaemia.

Mitra SS.

J Indian Med Assoc. 1981 Nov;77(9-10):153-5. No abstract available.

PMID:
7341688
37.

Infrared absorption of fluorozirconate glass in the 200-1800-cm(-1) frequency regime.

Bendow B, Drexhage MG, Lipson HG, Banerjee PK, Goltman J, Mitra SS, Moynihan CT.

Appl Opt. 1981 Sep 1;20(17). doi: 10.1364/AO.20.2875_1. No abstract available.

PMID:
20333056
38.
39.

ABO blood group distributions in diarrhoea cases including cholera in Calcutta.

Sircar BK, Dutta P, De SP, Sikdar SN, Deb BC, Pal SC, Mitra SS.

Ann Hum Biol. 1981 May-Jun;8(3):289-91.

PMID:
7259106
40.

Nutrition, anaemia and altered immunological response.

Mitra SS, Sinha AK.

J Assoc Physicians India. 1979 Aug;27(8):755-62. No abstract available.

PMID:
120368
41.

Optical phenomena in infrared materials: introduction.

Bendow B, Mitra SS.

Appl Opt. 1977 Nov 1;16(11):2805. doi: 10.1364/AO.16.002805.

PMID:
20174245
42.

Nonlinear absorption in direct-gap semiconductors.

Mitra SS, Narducci LM, Shatas RA, Tsay YF, Vaidyanathan A.

Appl Opt. 1975 Dec 1;14(12):3038-42. doi: 10.1364/AO.14.003038.

PMID:
20155149
43.

Erythrocytic glucose 6-phosphate dehydrogenase deficiency in thalassaemia syndromes--a cytochemical study.

Misra RC, Basu AK, Mitra SS.

J Indian Med Assoc. 1975 Jul 16;65(2):40-2. No abstract available.

PMID:
1194686
44.

Pressure and stress dependence of the refractive index of transparent crystals.

Bendow B, Gianino PD, Tsay YF, Mitra SS.

Appl Opt. 1974 Oct 1;13(10):2382-96. doi: 10.1364/AO.13.002382.

PMID:
20134694
45.

Observations on the intraerythrocytic distribution of foetal haemoglobin in Hb. E-thalassaemia disease.

Rakshit MM, Chatterjea JB, Mitra SS.

Indian J Pathol Bacteriol. 1973 Oct;16(4):41-5. No abstract available.

PMID:
4791521
46.

Interpretation of solid solution hardening with vibrational spectra.

Plendl JN, Gielisse PJ, Mansur LC, Mitra SS, Smakula A, Tarte PC.

Appl Opt. 1971 May 1;10(5):1129-33. doi: 10.1364/AO.10.001129.

PMID:
20094615
47.

Pressure Dependence of the Infrared-Active Phonons in the Mixed Crystal System KCl(1-x)Br(x).

Ferraro JR, Postmus C, Mitra SS, Hoskins CJ.

Appl Opt. 1970 Jan 1;9(1):5-10. doi: 10.1364/AO.9.000005.

PMID:
20076127
48.

Activity of pyruvate kinase (PK) and stability of ATP in heterozygous and homozygous states for Hb-E.

Mitra SS, Ghosh SK, Chatterjea JB.

Bull Calcutta Sch Trop Med. 1968 Oct;16(4):103-4. No abstract available.

PMID:
5731041
49.

Preliminary observations on the activity of pyruvate kinase in Hb. E thalassemia disease.

Mitra SS, Ghosh SK, Chatterjea JB.

Bull Calcutta Sch Trop Med. 1967 Jul;15(3):94-5. No abstract available.

PMID:
5616302
50.

On the constitution of the active principles isolated from the mature bark of Aegle marmelos, Correâ.

CHATTERJEE A, MITRA SS.

J Am Chem Soc. 1949 Feb;71(2):606-9. No abstract available.

PMID:
18112067

Supplemental Content

Loading ...
Support Center